| 產(chǎn)品名稱 |
Acinetobacter baumannii |
| 商品貨號 |
B161504 |
| Verified By |
Whole-genome Sequencing |
| Isolation |
Sputum of military personnel returning from Afghanistan entering a Canadian hospital, June 30, 2006 |
| Biosafety Level |
2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format |
freeze-dried |
| Storage Conditions |
Frozen: -80°C or colder
Freeze-Dried: 2°C to 8°C
Live Culture: See Propagation Section |
| Preceptrol® |
no |
| Type Strain |
no |
| Antibiotic Resistance |
Resistant to Ceftazidime, Gentamicin, Ticarcillin, Piperacillin, Aztreonam, Cefepime, Ciprofloxacin, Imipenem, and Meropemem. Sensitive to Amikacin and Tobramycin |
| Medium |
ATCC® Medium 18: Trypticase Soy Agar/Broth
|
| Growth Conditions |
Temperature: 37°C Atmosphere: Aerobic |
| Name of Depositor |
AE Simor |
| References |
Stuart, T.L., et.al. Acinetobacter baumannii in casualties retuning from Afghanistan. Can J of Infect Control 2007 Fall; 22(3): 152-154.
Tien H.C., et.al. Multi-drug resistant Acinetobacter infections in critically injured Canadian forces soldiers. BMC Infect Dis. 2007 Aug 14;7:95.
|
